Abstract
South Africa currently has an estimated 500,000 AIDS orphans, many of whom are HIV-positive. Oral candidiasis commonly occurs in both adult and paediatric HIV/AIDS patients. Published information on HIV-positive children in Africa mainly concerns hospitalised patients. The objective of this study was to determine the prevalence of oral candidiasis and oral yeast carriage among paediatric HIV/AIDS patients residing in orphanages in Gauteng, South Africa, and to compare the prevalence of isolated yeast species with species obtained from adult HIV/AIDS patients. Eighty-seven paediatric HIV/AIDS patients residing in five homes were examined and a swab taken from the dorsal surface of the tongue, cultured on CHROMagar and yeast isolates identified with the ATB 32C commercial system. The species prevalence of 57 identified isolates was compared with that of 330 isolates from adult HIV/AIDS patients. Twelve (13.8%) children presented with clinically detectable candidiasis. Yeasts were isolated from 0% to 53% of children in the individual homes, with Candida albicans (40.4%) and C. dubliniensis (26.3%) constituting the most frequently isolated species. Gentian violet prophylaxis was administered in one particular home and a higher carriage rate (66.6%) of non-C. albicans and non-C. dubliniensis was observed among these children. The prevalence of C. albicans was lower while the prevalence of C. dubliniensis, C. glabrata and C. tropicalis was significantly higher (p ≤ 0.001) among the children than among adult HIV/AIDS patients. These findings indicate a role for yeast culture and species determination in cases with candidiasis in institutionalized paediatric HIV/AIDS patients.
Similar content being viewed by others
References
Dorrington R, Bradshaw D, Budlender D. HIV/AIDS profile of the provinces of South Africa — indicators for 2002. Centre for Actuarial Research, Medical Research Council and the Actuarial Society of South Africa. 2002
Johnson L, Dorrington R. The impact of AIDS on orphanhood in South Africa: A quantitaive analysis. CARE Monograph No 4. 2001
Greenspan JS and Greenspan D (2002). The epidemiology of the oral lesions of HIV infection in the developed world. Oral Dis 8(Suppl 2): 34–39
Patton LL, Phelan JA, Ramos-Gomez FJ, Nittayananta W, Shiboski CH and Mbuguye TL (2002). Prevalence and classification of HIV-associated oral lesions. Oral Dis 8(Suppl 2): 98–109
Flaitz CM, Hicks MJ, Carter AB, Rossmann SN, Demmler GJ, Simon CL, et al. Saliva collection technique for cytologic, microbiologic and viral evaluation in pediatric HIV infection. ASDC J Dent Child 1998; 65(5): 318–324, 355
Flaitz C, Wullbrandt B, Sexton J, Bourdon T and Hicks J (2001). Prevalence of orodental findings in HIV-infected Romanian children. Pediatr Dent 23(1): 44–50
Kline MW (1996). Oral manifestiations of pediatric human immunodeficeincy virus infection: a review of the literature. Pediatrics 97(3): 380–388
Ramos-Gomez FJ, Flaitz C, Catapano P, Murray P, Milnes AR and Dorenbaum A (1999). Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV-infected pediatric patients. Collaborative Workgroup on Oral Manifestations of Pediatric HIV Infection. J Clin Pediatr Dent 23(2): 85–96
Ramos-Gomez FJ, Hilton JF, Canchola AJ, Greenspan D, Greenspan JS and Maldonado YA (1996). Risk factors for HIV-related orofacial soft-tissue manifestations in children. Pediatr Dent 18(2): 121–126
Pongsiriwet S, Iamaroon A, Kanjanavanit S, Pattanaporn K and Krisanaprakornkit S (2003). Oral lesions and dental caries status in perinatally HIV-infected children in Northern Thailand. Int J Paediatr Dent 13(3): 180–185
Flynn PM, Cunningham CK, Kerkering T, San Jorge AR, Peters VB and Pitel PA (1995). Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group. J Pediatr 127(2): 322–328
Jabra-Rizk MA, Enwonwu CO, Merz WG, Meiller TF, Falkler WA and Onwujekwe DI (2001). Prevalence of yeast among children in Nigeria and the United States. Oral Microbiol Immunol 16(6): 383–385
Reef SE, Lasker BA, Butcher DS, McNeil MM, Pruitt R and Keyserling H (1998). Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study. J Clin Microbiol 36(5): 1255–1259
Sharp AM, Odds FC and Evans EG (1992). Candida strains from neonates in a special care baby unit. Arch Dis Child 67(1 Spec No): 48–52
Mehta SK, Stevens DA, Mishra SK, Feroze F and Pierson DL (1999). Distribution of Candida albicans genotypes among family members. Diagn Microbiol Infect Dis 34(1): 19–25
Muller FM, Kasai M, Francesconi A, Brillante B, Roden M and Peter J (1999). Transmission of an azole-resistant isogenic strain of Candida albicans among human immunodeficiency virus-infected family members with oropharyngeal candidiasis. J Clin Microbiol 37(10): 3405–3408
Sullivan D and Coleman D (1997). Candida dubliniensis: an emerging opportunistic pathogen. Curr Top Med Mycol 8(1–2): 15–25
Sullivan D and Coleman D (1998). Candida dubliniensis: characteristics and identification. J Clin Microbiol 36(2): 329–334
Jabra-Rizk MA, Ferreira SM, Sabet M, Falkler WA, Merz WG and Meiller TF (2001). Recovery of Candida dubliniensis and other yeasts from human immunodeficiency virus-associated periodontal lesions. J Clin Microbiol 39(12): 4520–4522
Meiller TF, Jabra-Rizk MA, Baqui A, Kelley JI, Meeks VI and Merz WG (1999). Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88(5): 573–580
Scheutz F, Matee MI, Simon E, Mwinula JH, Lyamuya EF and Msengi AE (1997). Association between carriage of oral yeasts, malnutrition and HIV-1 infection among Tanzanian children aged 18 months to 5 years. Community Dent Oral Epidemiol 25(3): 193–198
Akpede GO, Ambe JP, Rabasa AI, Akuhwa TR, Ajayi BB and Akoma MA (1997). Presentation and outcome of HIV-1 infection in hospitalised infants and other children in north-eastern Nigeria. East Afr Med J 74(1): 21–27
Ferguson FS, Nachman S and Berentsen B (1997). Implications and management of oral diseases in children and adolescents with HIV infection. N Y State Dent J 63(2): 46–50
Gehrke FS and Johnsen DS (1991). Bottle caries associated with anti-HIV therapy. Pediatr Dent 13(1): 73
Madigan A, Murray PA, Houpt M, Catalanotto F and Feuerman M (1996). Caries experience and cariogenic markers in HIV-positive children and their siblings. Pediatr Dent 18(2): 129–136
Akdeniz BG, Koparal E, Sen BH, Ates M, Denizci AA. Prevalence of Candida albicans in oral cavities and root canals of children. ASDC J Dent Child 2002; 69(3): 289–292, 235
Beighton D and Lynch E (1993). Relationships between yeasts and primary root-caries lesions. Gerodontology 10(2): 105–108
Jacob LS, Flaitz CM, Nichols CM and Hicks MJ (1998). Role of dentinal carious lesions in the pathogenesis of oral candidiasis in HIV infection. J Am Dent Assoc 129(2): 187–194
Marchant S, Brailsford SR, Twomey AC, Roberts GJ and Beighton D (2001). The predominant microflora of nursing caries lesions. Caries Res 35(6): 397–406
Arendorf TM and Walker DM (1979). Oral candidal populations in health and disease. Br Dent J 147(10): 267–272
Odds FC and Bernaerts R (1994). CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 32(8): 1923–1929
Blignaut E, Messer S, Hollis RJ and Pfaller MA (2002). Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals. Diagn Microbiol Infect Dis 44(2): 169–174
Blignaut E, Botes M and Nieman H (1999). The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients. J SADA 54(12): 605–608
Khongkunthian P, Grote M, Isaratanan W, Piyaworawong S and Reichart PA (2001). Oral manifestations in 45 HIV-positive children from Northern Thailand. J Oral Pathol Med 30(9): 549–552
Arendorf T and Holmes H (2000). Oral manifestations associated with human immunodeficiency virus (HIV) infection in developing countries–are there differences from developed countries?. Oral Dis 6(3): 133–135
Henley LD (2002). End of life care in HIV-infected children who died in hospital. Developing World Bioeth 2(1): 38–54
Sano A, Vilela MM, Takahashi I, Fukushima K, Takizawa K and da Silva MT (2000). Isolation of Candida dubliniensis from the oral cavity of an HIV-positive child in Brazil. Nippon Ishinkin Gakkai Zasshi 41(3): 177–181
Blignaut E, Pujol C, Joly S and Soll DR (2003). Racial distribution of Candida dubliniensis colonization among South Africans. J Clin Microbiol 41(5): 1838–1842
Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ and Shanley DB (1997). Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 41(3): 617–623
Vazquez JA, Arganoza MT, Boikov D, Yoon S, Sobel JD and Akins RA (1998). Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles. J Clin Microbiol 36(9): 2690–2695
Cartledge JD, Midgely J and Gazzard BG (1997). Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis. AIDS 11: 1839–1844
Kleinegger CL, Lockhart SR, Vargas K and Soll DR (1996). Frequency, intensity, species, and strains of oral Candida vary as a function of host age. J Clin Microbiol 34(9): 2246–2254
Pfaller MA (2000). Epidemiology of nosocomial candidiasis: the importance of molecular typing. Braz J Infect Dis 4(4): 161–167
Ticklay IMH, Nathoo KJ, Siziya S and Brady JP (1997). HIV infection in malnourished children in Harare, Zimbabwe. East Afr Med J 74: 217–220
Flynn P, Cunningham C, Kerkering T, San Jorge A, Peters V and Pitel P (1995). Oropharyngeal candidiasis in immunocompromised children: A randomized, multicentre study of orally administered fluconazole suspensionversus nystatin. J Pediatr 127: 322–328
Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ and Jones RN (2003). In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J Clin Microbiol 41(1): 78–83
Diekema DJ, Pfaller MA, Messer SA, Houston A, Hollis RJ and Doern GV (1999). In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America. Antimicrob Agents Chemother 43(9): 2236–2239
Flaitz CM, Hicks MJ. Oral candidiasis in children with immune suppression: clinical appearance and therapeutic considerations. ASDC J Dent Child 1999; 66(3): 161–166, 154
Ball LM, Bes MA, Theelen B, Boekhout T, Egeler RM and Kuijper EJ (2004). Significance of amplified fragment length polymorphism in identification and epidemiological examination of Candida species colonization in children undergoing allogeneic stem cell transplantation. J Clin Microbiol 42(4): 1673–1679
Milnes AR (1996). Description and epidemiology of nursing caries. J Public Health Dent 56(1): 38–50
Horowitz A (1998). Response to Weinstein: public health issues in early childhood caries. Community Dent Oral Epidemiol 26(1): 91–95
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Blignaut, E. Oral candidiasis and oral yeast carriage among institutionalised South African paediatric HIV/AIDS patients. Mycopathologia 163, 67–73 (2007). https://doi.org/10.1007/s11046-006-0087-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-006-0087-9